Fingerprint
Dive into the research topics of 'Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically